Hovione has over 57 years of experience as a CDMO and is currently a fully integrated supplier offering from drug substance to drug product intermediate to drug product. With four FDA inspected sites, USA, China, Ireland and Portugal and development laboratories in Lisbon, Portugal and New Jersey, USA, Hovione provides branded pharmaceutical customers services for the development and compliant manufacture of innovative drugs including highly potent compounds. For generic pharmaceutical customers the company offers niche off-patent API products. Hovione also provides proprietary product development and licensing opportunities for drug products. Hovione is a member of Rx-360, EFCG and participates actively in industry quality improvement initiatives to lead new global industry standards. Hovione is a company with a culture based on innovation, quality and delivery and employs around 1,500 people worldwide. ÒWe do well what is difficult, to give our customers what they cannot find elsewhere.Ó